This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
MSM
MSM is the stable, odorless oxidation product of DMSO — "dry DMSO" in pill form — and the most studied organic-sulfur supplement.
Aliases (3)
Overview
What is MSM?
MSM is the stable, odorless oxidation product of DMSO — "dry DMSO" in pill form — and the most studied organic-sulfur supplement. Twenty-plus years of small-to-medium RCTs converge on the same picture: modest, reliable, well-tolerated improvement in joint pain (knee OA: ~10-25% WOMAC improvement at 3-6 g/day × 12 weeks), small reduction in post-exercise muscle soreness and oxidative stress at 3 g/day × 4+ weeks, and adjunctive benefit in seasonal allergic rhinitis. Effect size is small but consistent and the safety profile is excellent (LD50 in rats >17 g/kg; mild GI in <10% at typical doses). For this archetype: OPTIONAL-ADD at 3 g/day, two divided doses with meals, for 4-8 weeks, primarily for grappling/striking joint stress and as a sulfur donor for glutathione during a high-supplement load. Not a transformative ergogenic — expect ~15-20% reduction in chronic joint nags, not a fix-everything. Use OptiMSM (distilled, pharma-grade) and skip cheap crystallized brands.
Pharmacokinetics
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
classic joint stack; MSM provides sulfate substrate that chondroitin sulfate synthesis can use. Most over-the-counter "joint" products combine these three. M…
(Shaw protocol) — peri-training collagen + vitamin C for tendon synthesis; MSM provides sulfur for the sulfated GAGs in connective tissue matrix. Mechanistic…
independent anti-inflammatory pathway; additive effect on chronic joint pain and post-exercise inflammation. Both already V4-locked in this archetype's stack.
converging NF-kB and inflammatory cytokine inhibition. The Notarnicola MEBAGA trial validates MSM+boswellic acids as a real combination.
both are sulfur compounds; NAC directly donates cysteine for glutathione, MSM provides background sulfur substrate. Additive glutathione support during high …
antioxidant synergy; also cofactor for collagen synthesis which uses MSM-derived sulfur.
independent muscle recovery effects; no interaction concern.
different layer of joint support; HA hydrates cartilage matrix, MSM supports the GAG synthesis side. Common combination in OA stacks.
no pharmacological interaction. All compatible.
no interaction; functionally complementary (both target tissue repair, different mechanisms).
no interaction.
no documented interactions.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 8
Side Effects
- 1None reliably at typical doses (1.5-3 g/day). Most users report no side effects.
- 2Mild GI upset — bloating, soft stool, mild diarrhea. Most prominent first 3-7 days; usually resolves with continued use or by taking with food.
- 3Mild headache — uncommon, usually first week, often resolves.
- 4Mild insomnia — occasional reports, possibly via mild adrenergic activation; dose AM if affected.
- 5Skin reactions — rare, mostly with topical use.
- 6Sulfur-like body odor or breath at doses >6 g/day. Mostly cosmetic.
- 7Nausea — usually resolves with food co-administration.
- 8Allergic reactions — extremely rare; case reports of skin rash with sulfur sensitivity.
When to Stop
- No documented rare-serious reactions in 25+ years of widespread OTC use. LD50 in rats >17 g/kg (per Butawan/Horváth toxicology data — meaning a 70 kg human would need >1.2 kg single oral dose to approach lethality, which is functionally impossible). MSM is among the safest supplements available.
- First week: GI tolerance check — start at 1.5 g/day to confirm tolerability, then escalate. If persistent diarrhea or bloating, lower dose or stop.
- First 2 weeks: sleep onset — rare reports of mild insomnia; if seen, dose only at breakfast.
- High-dose users (>6 g/day): body odor monitoring — partner feedback or self-check. Drop to 3-4 g if cosmetic issue.
- Insufficient human data. No teratogenic signal in animal studies. Generally considered "likely safe" at typical food/supplement doses but not recommended without OB/GYN sign-off given lack of controlled human studies.
- MSM is NOT a sulfa drug. Sulfa allergies refer to sulfonamide antibiotics with a specific aromatic amine structure. MSM is a simple aliphatic sulfone and does not cross-react. People with sulfa-drug allergies can take MSM safely.
References
Kim LS et al. 2006 — Efficacy of MSM in osteoarthritis pain of the knee: a pilot RCT (PMID 16309928)
landmark 12-week double-blind placebo-controlled trial; 3 g MSM bid showed significant WOMAC pain and physical function improvement.
View StudyDebbi EM et al. 2011 — MSM supplementation on knee osteoarthritis: randomized controlled study (PMID 21708034)
49 patients, 3.375 g/day × 12 weeks; modest but statistically significant WOMAC improvement.
View StudyBrien S, Prescott P, Lewith G 2011 — Meta-analysis of DMSO and MSM for knee OA (PMID 19474240)
honest meta-analytic counter-position; pooled effect non-significant.
View StudyNotarnicola A et al. 2016 — MSM + boswellic acids vs glucosamine sulfate in knee arthritis (MEBAGA, PMID 26684635)
MSM+BA non-inferior to glucosamine over 6 months.
View StudyToguchi A et al. 2023 — MSM improves knee QoL in mild knee pain: RCT (PMID 37447322)
88 Japanese participants, 2 g/day × 12 weeks; significant JKOM improvement.
View StudyKalman DS et al. 2012 — MSM on markers of exercise recovery: pilot study (PMID 23013531)
1.5 g vs 3 g/day OptiMSM × 30 days; trend toward reduced soreness and significant TEAC increase at 3 g.
View StudyWithee ED et al. 2017 — MSM on exercise-induced oxidative stress, muscle damage, pain post half-marathon (PMID 28736511)
22 trained runners, 3 g/day × 21 days; reduced post-race pain and some oxidative stress markers.
View StudyButawan M, Benjamin RL, Bloomer RJ 2017 — MSM: applications and safety of a novel dietary supplement (PMID 28300758)
comprehensive modern review; mechanism, applications, GRAS safety profile.
View StudyBarrager E et al. 2002 — MSM in seasonal allergic rhinitis: open-label trial (PMID 12006124)
55 subjects, 2.6 g/day × 30 days; significant respiratory symptom reduction without IgE/histamine change.
View StudyCrowley DC et al. 2018 — Small intestinal absorption of MSM and tissue sulfur accumulation in mice (PMID 29295596)
passive carrier-independent absorption, high capacity.
View StudyEzaki J et al. 2013 — MSM safety and efficacy on bone and knee joints in OA animal model (PMID 23011466)
STR/Ort mouse model; dose-dependent cartilage protection, organ atrophy at very high doses.
View StudyCrawford P et al. 2017 — MSM vs placebo for knee pain prevention in military trainees (PMID 29214616)
mixed results in healthy military population.
View StudyHewlings S, Kalman DS 2018 — MSM allergic rhinitis allergen challenge RCT (PMC6293242)
follow-up study with mixed results on allergen challenge.
View StudyMethylsulfonylmethane — Wikipedia (2026)
general chemistry, history, regulatory status.
View StudyOptiMSM (Bergstrom Nutrition) — manufacturer product overview
distilled pharma-grade MSM specifications and third-party testing.
View StudyMedlinePlus — Methylsulfonylmethane (MSM) consumer monograph
consumer-tier summary; dosing, interactions, side effects.
View StudyFDA GRAS notification — methylsulfonylmethane (GRN 229)
regulatory basis for GRAS status at typical dietary supplement doses.
View StudyLatest research
- rctMSM improves knee quality of life in mild knee pain (RCT, 12 weeks, 2 g/day)88 healthy Japanese participants with mild knee pain, 2 g/day MSM × 12 wk; significant improvement in JKOM total knee QoL score vs placebo (p=0.046).
- rctMSM on exercise-induced oxidative stress, muscle damage, and pain post half-marathon (RCT)3 g/day MSM × 21 days pre-event reduced post-race muscle and joint pain, attenuated some oxidative stress markers; n=22 trained runners.
- reviewMSM applications and safety — comprehensive reviewModern reference (Butawan/Bloomer) on MSM mechanism, joint/recovery applications, GRAS safety profile, and dosing.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.